Abstract
Background: Glucocorticoid excess leads to muscle atrophy and weakness in patients with endogenous Cushing's syndrome. Insulin-like growth factor I (IGF-I) is known to have protective effects on muscle loss. We hypothesized that individual serum IGF-I concentrations might be predictive for long-term myopathy outcome in Cushing's syndrome. Patients and methods: In a prospective longitudinal study of 31 patients with florid Cushing's syndrome, we analyzed IGF-I and IGF binding protein 3 (IGFBP 3) concentrations at the time of diagnosis and following surgical remission over a period of up to 3 years. We assessed muscle strength by grip strength measurements using a hand grip dynamometer and muscle mass by bio-impedance measurements. Findings: Individual serum IGF-I concentrations in the postoperative phase were strongly predictive of long-term grip strength outcome (r(s)= 0.696, P < 0.001). Also, lower IGF-I concentrations were associated with a lower muscle mass after 3 years (r(s)= 0.404, P = 0.033). While patients with high IGF-I s.D. scores (SDS;>1.4) showed an improvement in grip strength within the follow-up period (P = 0.009), patients with lower IGF-I sDs (<-0.4) had a worse outcome with persisting muscle dysfunction. In contrast, preoperative IGF-I concentrations during the florid phase of Cushing's syndrome did not predict long-term muscle function outcome (r(s)= 0.285, P = 0.127). Conclusion: Lower individual IGF-I concentrations 6 months after curative surgery for Cushing's syndrome are associated with adverse long-term myopathy outcome and IGF-I might be essential for muscle regeneration in the early phase after correction of hypercortisolism.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 0804-4643 |
Sprache: | Englisch |
Dokumenten ID: | 102820 |
Datum der Veröffentlichung auf Open Access LMU: | 05. Jun. 2023, 15:41 |
Letzte Änderungen: | 18. Okt. 2023, 12:48 |